Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy

Multiple myeloma (MM) is a plasma cell dyscrasia characterized by the clonal proliferation of antibody producing plasma cells. Despite the use of next generation proteasome inhibitors (PI), immunomodulatory agents (IMiDs) and immunotherapy, the development of therapy refractory disease is common, wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Remya, Gupta, Pulkit, Shanmugam, Mala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523312/
https://www.ncbi.nlm.nih.gov/pubmed/36185202
http://dx.doi.org/10.3389/fonc.2022.1000106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523312/
https://www.ncbi.nlm.nih.gov/pubmed/36185202
http://dx.doi.org/10.3389/fonc.2022.1000106

Ejemplares similares